This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Wacker Chemie Ag. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Antje Parthier: Innovator in Biotech
Introduction
Antje Parthier is a notable inventor based in Halle/Saale, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of proNGF mutants for medical applications. With a total of 2 patents, her work is paving the way for advancements in human health.
Latest Patents
Antje's latest patents focus on the production of biologically active human beta-NGF from inactive proNGF mutants. The inventions detail methods for preparing these mutants, which are crucial for producing human beta-NGF. Specifically, her patents describe a proNGF mutant that is substituted by any amino acid except Arg or Lys at the native protease cleavage site, ensuring the effectiveness of the resulting beta-NGF.
Career Highlights
Antje Parthier is currently employed at Wacker Chemie AG, a leading company in the chemical industry. Her role involves extensive research and development in biotechnology, where she applies her expertise to innovate and improve existing processes.
Collaborations
Antje collaborates with talented coworkers, including Susan Lorey and Bernhard Janowski. These partnerships enhance her research efforts and contribute to the success of her projects.
Conclusion
Antje Parthier's work in biotechnology, particularly her innovations related to proNGF mutants, showcases her dedication to advancing medical science. Her contributions are significant in the ongoing quest for effective treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile